The Early Course of Radiographic Progression in Axial Spondyloarthritis: Have We Missed Something?

REFERENCES

1. 1.↵
   1. Dougados M,
   2. d’Agostino MA,
   3. Benessiano J, et al.

   The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. Joint Bone Spine 2011;78:598-603.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Molto A,
   2. López-Medina C,
   3. Sepriano A, et al.

   Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort. Ann Rheum Dis 2024;83:858-64.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Ramiro S,
   2. van der Heijde D,
   3. van Tubergen A, et al.

   Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 2014;73:1455-61.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Dougados M,
   2. Sepriano A,
   3. Molto A, et al.

   Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort. Ann Rheum Dis 2017;76:1823-8.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Poddubnyy D,
   2. Rudwaleit M,
   3. Haibel H, et al.

   Rates and predictors of radiographic sacroiliitis progression over 2 years in patients with axial spondyloarthritis. Ann Rheum Dis 2011;70:1369-74.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Poddubnyy D,
   2. Sieper J,
   3. Akar S, et al.

   Radiographic progression in sacroiliac joints in patients with axial spondyloarthritis: results from a five-year international observational study. ACR Open Rheumatol 2024;6:103-10.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Torgutalp M,
   2. Rios Rodriguez V,
   3. Proft F, et al.

   Treatment with tumor necrosis factor inhibitors is associated with a time-shifted retardation of radiographic sacroiliitis progression in patients with axial spondyloarthritis: 10-year results from the German Spondyloarthritis Inception Cohort. Arthritis Rheumatol 2022;74:1515-23.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Gran JT,
   2. Skomsvoll JF.

   The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol 1997;36:766-71.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Barkham N,
   2. Keen HI,
   3. Coates LC, et al.

   Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis. Arthritis Rheum 2009;60:946-54.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Sieper J,
    2. Lenaerts J,
    3. Wollenhaupt J, et al.

    Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, part 1. Ann Rheum Dis 2014;73:101-7.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Li Z,
    2. van der Linden SM,
    3. Khan MA, et al.

    Heterogeneity of axial spondyloarthritis: genetics, sex and structural damage matter. RMD Open 2022;8:e002302.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Hebeisen M,
    2. Micheroli R,
    3. Scherer A, et al.

    Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: data from the Swiss Clinical Quality Management cohort. PLoS ONE 2020;15:e0230268.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. van Tubergen A,
    2. Heuft-Dorenbosch L,
    3. Schulpen G, et al.

    Radiographic assessment of sacroiliitis by radiologists and rheumatologists: does training improve quality? Ann Rheum Dis 2003;62:519-25.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Sepriano A,
    2. Rudwaleit M,
    3. Sieper J,
    4. van den Berg R,
    5. Landewé R,
    6. van der Heijde D.

    Five-year follow-up of radiographic sacroiliitis: progression as well as improvement? Ann Rheum Dis 2016;75:1262-3.

    OpenUrlFREE Full Text
15. 15.↵
    1. Deodhar A,
    2. Strand V,
    3. Kay J,
    4. Braun J.

    The term “non-radiographic axial spondyloarthritis” is much more important to classify than to diagnose patients with axial spondyloarthritis. Ann Rheum Dis 2016;75:791-4.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. van der Heijde D,
    2. Joshi A,
    3. Pangan AL, et al.

    ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical trial translate to meaningful improvements in physical function, health-related quality of life and work productivity in patients with non-radiographic axial spondyloarthritis. Rheumatology 2016;55:80-8.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Diekhoff T,
    2. Greese J,
    3. Sieper J,
    4. Poddubnyy D,
    5. Hamm B,
    6. Hermann KA.

    Improved detection of erosions in the sacroiliac joints on MRI with volumetric interpolated breath-hold examination (VIBE): results from the SIMACT study. Ann Rheum Dis 2018;77:1585-9.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Krabbe S,
    2. Møller JM,
    3. Hadsbjerg AEF, et al.

    Detection of structural lesions of the sacroiliac joints in patients with spondyloarthritis: a comparison of T1-weighted 3D spoiled gradient echo MRI and MRI-based synthetic CT versus T1-weighted turbo spin echo MRI. Skeletal Radiol 2024;53:2459-68.

    OpenUrlPubMed
19. 19.↵
    1. Protopopov M,
    2. Sieper J,
    3. Haibel H,
    4. Listing J,
    5. Rudwaleit M,
    6. Poddubnyy D.

    Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Arthritis Res Ther 2017;19:240.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Protopopov M,
    2. Proft F,
    3. Wichuk S, et al.

    Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort. Rheumatology 2023;62:1631-5.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. de Bruin F,
    2. de Koning A,
    3. van den Berg R, et al.

    Development of the CT Syndesmophyte Score (CTSS) in patients with ankylosing spondylitis: data from the SIAS cohort. Ann Rheum Dis 2018;77:371-7.

    OpenUrlAbstract/FREE Full Text
22. 22.↵
    1. van der Heijde D,
    2. Braun J,
    3. Deodhar A, et al.

    Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis. Rheumatology 2019;58:388-400.

    OpenUrlCrossRefPubMed